CFHR3 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test
Comprehensive Genetic Analysis for Kidney Health
The CFHR3 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for kidney-related disorders. This advanced test specifically targets the CFHR3 gene, which plays a critical role in regulating the complement system – an essential component of our immune defense mechanism. When mutations occur in this gene, it can lead to atypical hemolytic uremic syndrome (aHUS), a rare but serious condition affecting kidney function and blood cell integrity.
What Does This Test Measure?
This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the CFHR3 gene for:
- Point mutations and single nucleotide variations
- Gene deletions and duplications
- Structural variations affecting gene function
- Regulatory region abnormalities
- Inheritance patterns and familial risk assessment
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Unexplained kidney failure or dysfunction
- Recurrent episodes of hemolytic anemia
- Persistent low platelet counts (thrombocytopenia)
- Family history of kidney disorders or aHUS
- Unexplained hypertension in young adults
- Multiple family members with kidney disease
- Children with atypical kidney symptoms
Key Benefits of Genetic Testing
Undergoing the CFHR3 Gene Hemolytic Uremic Syndrome test provides numerous advantages:
- Early Detection: Identify genetic predisposition before symptoms manifest
- Personalized Treatment: Guide targeted therapy decisions
- Family Planning: Inform reproductive choices and genetic counseling
- Proactive Monitoring: Enable regular health surveillance for at-risk individuals
- Peace of Mind: Reduce uncertainty through definitive genetic information
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors:
- Positive Result: Indicates presence of CFHR3 gene mutation, requiring specialized medical management
- Negative Result: Suggests typical CFHR3 gene function, though continued monitoring may be recommended
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important for family planning and genetic counseling purposes
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | CFHR3 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our comprehensive network ensures that quality genetic testing is accessible to everyone, regardless of location.
Take Control of Your Health Today
Don’t let uncertainty about your genetic health hold you back. The CFHR3 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test provides the clarity you need to make informed healthcare decisions. Our team of genetic specialists is ready to guide you through the testing process and help interpret your results.
Book your test now or call our genetic counseling hotline at +1(267) 388-9828 to schedule your consultation and take the first step toward understanding your genetic health profile.
